Share Price and Basic Stock Data
Last Updated: December 18, 2025, 10:38 pm
| PEG Ratio | -33.25 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Zodiac JRD MKJ Ltd operates in the gems and jewellery sector, a space known for its volatility yet potential for high returns. The company has seen a tumultuous revenue trajectory over the years, with sales reported at ₹15.10 Cr for FY 2023, a decline from ₹19.02 Cr in FY 2022. However, the trailing twelve months (TTM) revenue stands at ₹20.72 Cr, suggesting a recovery trend. This fluctuation can be attributed to various market dynamics, including changing consumer preferences and pricing pressures in the jewellery sector. Interestingly, the company reported a significant uptick in sales in the June 2024 quarter, reaching ₹6.46 Cr, indicating a possible resurgence in demand. However, the overall sales have been inconsistent, with quarterly figures showing both peaks and troughs, reflecting the unpredictable nature of the market. A closer look reveals that the sales numbers are heavily reliant on seasonal demand, which can be a double-edged sword for investors.
Profitability and Efficiency Metrics
Profitability remains a key area of concern for Zodiac JRD MKJ. The reported operating profit margin (OPM) for FY 2025 stands at a mere 2.91%, a stark contrast to the previous year’s negative margins. This suggests that while the company is managing to turn a profit, the margins are thin, which could be a red flag for potential investors. The net profit for FY 2025 was recorded at ₹0.43 Cr, a recovery from the previous year’s loss of ₹1.37 Cr. However, the overall return on equity (ROE) of 0.63% and return on capital employed (ROCE) of 1.41% signal a need for improved operational efficiency. The cash conversion cycle (CCC) is notably long at 1,059.20 days, which indicates that the company may be taking too long to convert its investments in inventory back into cash. This inefficiency could hinder its ability to reinvest into growth opportunities.
Balance Sheet Strength and Financial Ratios
The balance sheet of Zodiac JRD MKJ Ltd appears relatively strong, with total borrowings reported at just ₹0.24 Cr, indicating minimal leverage. This low debt level is a positive aspect, as it suggests financial stability and reduced risk during downturns. The company’s reserves have shown a healthy increase, standing at ₹80.23 Cr, which provides a buffer against operational volatility. However, the price-to-book value (P/BV) ratio is at 0.41x, which may indicate that the stock is undervalued relative to its book value. On the liquidity front, the current ratio is a staggering 30.69, suggesting that the company is well-positioned to meet its short-term obligations. However, the interest coverage ratio (ICR) of 2.89x, while adequate, highlights that the company needs to maintain a careful balance between profitability and interest obligations, particularly if market conditions were to deteriorate.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Zodiac JRD MKJ Ltd has witnessed notable shifts, particularly among promoters and public shareholders. As of September 2025, promoters hold 28.41% of the shares, down from 45.80% in December 2022. This decline could raise concerns about management confidence in the company’s future. On the flip side, public ownership has increased to 71.59%, which could reflect growing interest from retail investors. The total number of shareholders has also risen to 4,693, indicating a broader base of ownership. This shift could be interpreted as a double-edged sword: while increased public ownership may enhance liquidity, the diminishing promoter stake could signal a lack of confidence in the company’s strategic direction. Investors should keep an eye on these trends as they can impact stock performance and market sentiment significantly.
Outlook, Risks, and Final Insight
Looking ahead, Zodiac JRD MKJ faces both opportunities and risks that could shape its trajectory. The resurgence in sales and improving profitability metrics could indicate a turnaround, but this is tempered by the company’s ongoing struggles with operational efficiency and the long cash conversion cycle. The jewellery market remains competitive and susceptible to consumer trends, which adds an element of unpredictability. Additionally, the decline in promoter shareholding may raise questions about the management’s commitment to the company’s long-term vision. Investors should weigh these factors carefully. The stock may appeal to those looking for potential value plays in the gems and jewellery sector, but the risks associated with profitability and market volatility cannot be overlooked. A cautious approach, focusing on both the recovery signals and the underlying challenges, would be prudent for any investor considering an entry into Zodiac JRD MKJ Ltd.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mini Diamonds (India) Ltd | 312 Cr. | 26.4 | 43.6/19.5 | 75.1 | 5.54 | 0.00 % | 16.2 % | 12.6 % | 2.00 |
| Mishka Exim Ltd | 62.2 Cr. | 43.0 | 67.0/25.0 | 76.8 | 15.8 | 0.00 % | 2.29 % | 1.60 % | 10.0 |
| Motisons Jewellers Ltd | 1,546 Cr. | 15.7 | 31.0/14.6 | 27.7 | 4.50 | 0.00 % | 14.5 % | 11.6 % | 1.00 |
| Nanavati Ventures Ltd | 46.7 Cr. | 100 | 163/55.2 | 195 | 48.2 | 0.00 % | 1.39 % | 1.03 % | 10.0 |
| Gautam Gems Ltd | 15.8 Cr. | 3.86 | 5.44/3.41 | 43.8 | 12.6 | 0.00 % | 1.35 % | 0.55 % | 10.0 |
| Industry Average | 1,219.33 Cr | 86.86 | 55.12 | 89.57 | 0.16% | 6.93% | 5.13% | 6.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.96 | 0.13 | 1.03 | 1.09 | 5.93 | 1.91 | 3.04 | 0.00 | 6.46 | 6.23 | 5.54 | 4.75 | 4.20 |
| Expenses | 12.09 | 0.16 | 1.07 | 1.53 | 6.13 | 1.58 | 4.13 | 3.07 | 6.50 | 5.96 | 5.22 | 4.60 | 4.02 |
| Operating Profit | 0.87 | -0.03 | -0.04 | -0.44 | -0.20 | 0.33 | -1.09 | -3.07 | -0.04 | 0.27 | 0.32 | 0.15 | 0.18 |
| OPM % | 6.71% | -23.08% | -3.88% | -40.37% | -3.37% | 17.28% | -35.86% | -0.62% | 4.33% | 5.78% | 3.16% | 4.29% | |
| Other Income | 0.07 | 0.00 | 0.24 | 0.45 | 1.20 | 0.09 | 0.16 | 0.55 | 0.09 | 0.09 | 0.00 | 0.16 | 0.03 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.09 | 0.13 | 0.09 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.94 | -0.03 | 0.20 | 0.01 | 1.00 | 0.42 | -0.93 | -2.52 | 0.04 | 0.29 | 0.22 | 0.17 | 0.11 |
| Tax % | 25.53% | 200.00% | -40.00% | -1,000.00% | 12.00% | -14.29% | 1.08% | -28.97% | 0.00% | 0.00% | 0.00% | 105.88% | 0.00% |
| Net Profit | 0.70 | -0.10 | 0.28 | 0.11 | 0.89 | 0.47 | -0.94 | -1.79 | 0.04 | 0.28 | 0.21 | -0.01 | 0.11 |
| EPS in Rs | 0.64 | -0.09 | 0.25 | 0.10 | 0.81 | 0.43 | -0.85 | -1.63 | 0.04 | 0.25 | 0.19 | -0.01 | 0.10 |
Last Updated: August 1, 2025, 9:00 am
Below is a detailed analysis of the quarterly data for Zodiac JRD MKJ LTD based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 4.20 Cr.. The value appears to be declining and may need further review. It has decreased from 4.75 Cr. (Mar 2025) to 4.20 Cr., marking a decrease of 0.55 Cr..
- For Expenses, as of Jun 2025, the value is 4.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.60 Cr. (Mar 2025) to 4.02 Cr., marking a decrease of 0.58 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.15 Cr. (Mar 2025) to 0.18 Cr., marking an increase of 0.03 Cr..
- For OPM %, as of Jun 2025, the value is 4.29%. The value appears strong and on an upward trend. It has increased from 3.16% (Mar 2025) to 4.29%, marking an increase of 1.13%.
- For Other Income, as of Jun 2025, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.16 Cr. (Mar 2025) to 0.03 Cr., marking a decrease of 0.13 Cr..
- For Interest, as of Jun 2025, the value is 0.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.13 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.04 Cr..
- For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.11 Cr.. The value appears to be declining and may need further review. It has decreased from 0.17 Cr. (Mar 2025) to 0.11 Cr., marking a decrease of 0.06 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 105.88% (Mar 2025) to 0.00%, marking a decrease of 105.88%.
- For Net Profit, as of Jun 2025, the value is 0.11 Cr.. The value appears strong and on an upward trend. It has increased from -0.01 Cr. (Mar 2025) to 0.11 Cr., marking an increase of 0.12 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.10. The value appears strong and on an upward trend. It has increased from -0.01 (Mar 2025) to 0.10, marking an increase of 0.11.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.07 | 20.23 | 16.09 | 18.06 | 20.00 | 14.85 | 12.54 | 8.67 | 19.02 | 15.10 | 10.89 | 22.99 | 20.27 |
| Expenses | 19.79 | 19.08 | 15.39 | 17.37 | 20.67 | 14.50 | 12.39 | 8.71 | 18.29 | 14.85 | 14.92 | 22.32 | 19.32 |
| Operating Profit | 1.28 | 1.15 | 0.70 | 0.69 | -0.67 | 0.35 | 0.15 | -0.04 | 0.73 | 0.25 | -4.03 | 0.67 | 0.95 |
| OPM % | 6.07% | 5.68% | 4.35% | 3.82% | -3.35% | 2.36% | 1.20% | -0.46% | 3.84% | 1.66% | -37.01% | 2.91% | 4.69% |
| Other Income | 8.94 | 0.37 | 0.27 | 1.04 | 1.44 | 1.66 | 0.59 | 0.31 | 0.32 | 0.87 | 2.01 | 0.35 | 0.27 |
| Interest | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.35 | 0.37 |
| Depreciation | 0.12 | 0.24 | 0.06 | 0.06 | 0.07 | 0.05 | 0.03 | 0.02 | 0.02 | 0.01 | 0.00 | 0.06 | 0.04 |
| Profit before tax | 10.10 | 1.27 | 0.91 | 1.67 | 0.70 | 1.96 | 0.71 | 0.25 | 1.03 | 1.11 | -2.03 | 0.61 | 0.81 |
| Tax % | 28.12% | 40.16% | 30.77% | 23.35% | -2.86% | 23.47% | 29.58% | -40.00% | 33.98% | 10.81% | -32.51% | 29.51% | |
| Net Profit | 7.27 | 0.77 | 0.63 | 1.28 | 0.73 | 1.51 | 0.49 | 0.34 | 0.68 | 0.98 | -1.37 | 0.43 | 0.62 |
| EPS in Rs | 6.61 | 0.70 | 0.57 | 1.16 | 0.66 | 1.37 | 0.45 | 0.31 | 0.62 | 0.89 | -1.25 | 0.39 | 0.56 |
| Dividend Payout % | 3.56% | 33.64% | 41.11% | 20.23% | 35.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -89.41% | -18.18% | 103.17% | -42.97% | 106.85% | -67.55% | -30.61% | 100.00% | 44.12% | -239.80% | 131.39% |
| Change in YoY Net Profit Growth (%) | 0.00% | 71.23% | 121.36% | -146.14% | 149.82% | -174.40% | 36.94% | 130.61% | -55.88% | -283.91% | 371.18% |
Zodiac JRD MKJ LTD has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 13% |
| 3 Years: | 7% |
| TTM: | 82% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | 0% |
| 3 Years: | -13% |
| TTM: | 127% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 19% |
| 3 Years: | 14% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -1% |
| 3 Years: | -1% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 1:56 pm
Balance Sheet
Last Updated: December 4, 2025, 2:15 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 10.98 |
| Reserves | 58.21 | 58.67 | 58.98 | 59.54 | 59.97 | 61.17 | 61.66 | 62.02 | 62.71 | 63.69 | 62.32 | 62.75 | 80.23 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 | 0.49 | 0.24 |
| Other Liabilities | 9.58 | 4.91 | 6.16 | 2.03 | 1.49 | 1.29 | 1.35 | 0.72 | 1.04 | 0.81 | 0.11 | 1.97 | 3.22 |
| Total Liabilities | 72.97 | 68.76 | 70.32 | 66.75 | 66.64 | 67.64 | 68.19 | 67.92 | 68.93 | 69.68 | 67.92 | 70.39 | 94.67 |
| Fixed Assets | 0.74 | 0.52 | 0.47 | 0.44 | 0.37 | 0.32 | 0.29 | 0.26 | 0.24 | 0.04 | 0.52 | 0.44 | 0.41 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.06 | 0.06 |
| Investments | 15.11 | 12.54 | 10.74 | 9.85 | 8.54 | 5.21 | 5.59 | 2.94 | 1.74 | 1.70 | 0.00 | 0.00 | 19.70 |
| Other Assets | 57.12 | 55.70 | 59.11 | 56.46 | 57.73 | 62.11 | 62.31 | 64.72 | 66.95 | 67.94 | 67.34 | 69.89 | 74.50 |
| Total Assets | 72.97 | 68.76 | 70.32 | 66.75 | 66.64 | 67.64 | 68.19 | 67.92 | 68.93 | 69.68 | 67.92 | 70.39 | 94.67 |
Below is a detailed analysis of the balance sheet data for Zodiac JRD MKJ LTD based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.98 Cr.. The value appears strong and on an upward trend. It has increased from 5.18 Cr. (Mar 2025) to 10.98 Cr., marking an increase of 5.80 Cr..
- For Reserves, as of Sep 2025, the value is 80.23 Cr.. The value appears strong and on an upward trend. It has increased from 62.75 Cr. (Mar 2025) to 80.23 Cr., marking an increase of 17.48 Cr..
- For Borrowings, as of Sep 2025, the value is 0.24 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.49 Cr. (Mar 2025) to 0.24 Cr., marking a decrease of 0.25 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3.22 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.97 Cr. (Mar 2025) to 3.22 Cr., marking an increase of 1.25 Cr..
- For Total Liabilities, as of Sep 2025, the value is 94.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 70.39 Cr. (Mar 2025) to 94.67 Cr., marking an increase of 24.28 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.41 Cr.. The value appears to be declining and may need further review. It has decreased from 0.44 Cr. (Mar 2025) to 0.41 Cr., marking a decrease of 0.03 Cr..
- For CWIP, as of Sep 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.06 Cr..
- For Investments, as of Sep 2025, the value is 19.70 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 19.70 Cr., marking an increase of 19.70 Cr..
- For Other Assets, as of Sep 2025, the value is 74.50 Cr.. The value appears strong and on an upward trend. It has increased from 69.89 Cr. (Mar 2025) to 74.50 Cr., marking an increase of 4.61 Cr..
- For Total Assets, as of Sep 2025, the value is 94.67 Cr.. The value appears strong and on an upward trend. It has increased from 70.39 Cr. (Mar 2025) to 94.67 Cr., marking an increase of 24.28 Cr..
Notably, the Reserves (80.23 Cr.) exceed the Borrowings (0.24 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.28 | 1.15 | 0.70 | 0.69 | -0.67 | 0.35 | 0.15 | -0.04 | 0.73 | 0.25 | -4.34 | 0.18 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 240.97 | 197.75 | 240.69 | 339.94 | 261.89 | 290.28 | 289.90 | 455.93 | 369.41 | 413.10 | 405.89 | 296.89 |
| Inventory Days | 826.97 | 911.70 | 1,320.57 | 950.27 | 815.81 | 1,235.08 | 1,568.56 | 2,237.20 | 877.37 | 1,160.59 | 1,544.13 | 762.31 |
| Days Payable | 117.50 | 9.59 | 68.38 | 44.25 | 24.82 | 21.08 | 29.89 | 22.92 | 10.81 | 13.86 | 1.31 | 0.00 |
| Cash Conversion Cycle | 950.43 | 1,099.86 | 1,492.88 | 1,245.96 | 1,052.88 | 1,504.28 | 1,828.57 | 2,670.21 | 1,235.98 | 1,559.83 | 1,948.71 | 1,059.20 |
| Working Capital Days | 815.23 | 904.47 | 1,195.72 | 1,089.14 | 1,013.79 | 1,409.37 | 1,710.32 | 2,531.42 | 1,164.47 | 1,454.44 | 2,011.35 | 981.01 |
| ROCE % | 2.59% | 1.74% | 1.31% | 1.38% | 1.08% | 0.20% | 0.93% | -1.72% | 1.48% | 1.13% | -4.62% | 1.41% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.83 | -2.64 | 1.90 | 1.32 | 0.67 |
| Diluted EPS (Rs.) | 0.83 | -2.64 | 1.90 | 1.32 | 0.67 |
| Cash EPS (Rs.) | 0.94 | -2.63 | 1.93 | 1.36 | 0.71 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 131.21 | 130.38 | 133.02 | 131.12 | 129.79 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 131.21 | 130.38 | 133.02 | 131.12 | 129.79 |
| Revenue From Operations / Share (Rs.) | 44.40 | 21.02 | 29.17 | 36.73 | 16.75 |
| PBDIT / Share (Rs.) | 1.97 | -3.92 | 2.16 | 2.03 | 0.51 |
| PBIT / Share (Rs.) | 1.86 | -3.93 | 2.13 | 1.99 | 0.47 |
| PBT / Share (Rs.) | 1.18 | -3.94 | 2.13 | 1.99 | 0.47 |
| Net Profit / Share (Rs.) | 0.82 | -2.64 | 1.90 | 1.32 | 0.66 |
| PBDIT Margin (%) | 4.44 | -18.65 | 7.41 | 5.52 | 3.10 |
| PBIT Margin (%) | 4.18 | -18.69 | 7.31 | 5.41 | 2.83 |
| PBT Margin (%) | 2.64 | -18.72 | 7.31 | 5.41 | 2.83 |
| Net Profit Margin (%) | 1.86 | -12.57 | 6.51 | 3.59 | 3.97 |
| Return on Networth / Equity (%) | 0.63 | -2.02 | 1.42 | 1.00 | 0.51 |
| Return on Capital Employeed (%) | 1.41 | -3.00 | 1.60 | 1.51 | 0.36 |
| Return On Assets (%) | 0.60 | -2.01 | 1.41 | 0.99 | 0.50 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.33 | 0.15 | 0.21 | 0.27 | 0.12 |
| Current Ratio (X) | 30.69 | 420.74 | 100.40 | 72.76 | 111.05 |
| Quick Ratio (X) | 10.99 | 120.86 | 37.49 | 28.02 | 28.88 |
| Inventory Turnover Ratio (X) | 0.50 | 0.00 | 0.01 | 0.00 | 0.01 |
| Interest Coverage Ratio (X) | 2.89 | -580.06 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 2.21 | -390.23 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 23.72 | 28.28 | 7.84 | 11.09 | 9.36 |
| EV / Net Operating Revenue (X) | 1.03 | 2.60 | 0.51 | 0.58 | 1.08 |
| EV / EBITDA (X) | 23.23 | -13.93 | 7.00 | 10.55 | 34.81 |
| MarketCap / Net Operating Revenue (X) | 1.23 | 3.10 | 0.97 | 0.86 | 1.49 |
| Price / BV (X) | 0.41 | 0.49 | 0.21 | 0.24 | 0.19 |
| Price / Net Operating Revenue (X) | 1.23 | 3.10 | 0.97 | 0.86 | 1.49 |
| EarningsYield | 0.01 | -0.04 | 0.06 | 0.04 | 0.02 |
After reviewing the key financial ratios for Zodiac JRD MKJ LTD, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 5. It has increased from -2.64 (Mar 24) to 0.83, marking an increase of 3.47.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 5. It has increased from -2.64 (Mar 24) to 0.83, marking an increase of 3.47.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 3. It has increased from -2.63 (Mar 24) to 0.94, marking an increase of 3.57.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.21. It has increased from 130.38 (Mar 24) to 131.21, marking an increase of 0.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.21. It has increased from 130.38 (Mar 24) to 131.21, marking an increase of 0.83.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 44.40. It has increased from 21.02 (Mar 24) to 44.40, marking an increase of 23.38.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.97. This value is below the healthy minimum of 2. It has increased from -3.92 (Mar 24) to 1.97, marking an increase of 5.89.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.86. This value is within the healthy range. It has increased from -3.93 (Mar 24) to 1.86, marking an increase of 5.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.18. This value is within the healthy range. It has increased from -3.94 (Mar 24) to 1.18, marking an increase of 5.12.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 2. It has increased from -2.64 (Mar 24) to 0.82, marking an increase of 3.46.
- For PBDIT Margin (%), as of Mar 25, the value is 4.44. This value is below the healthy minimum of 10. It has increased from -18.65 (Mar 24) to 4.44, marking an increase of 23.09.
- For PBIT Margin (%), as of Mar 25, the value is 4.18. This value is below the healthy minimum of 10. It has increased from -18.69 (Mar 24) to 4.18, marking an increase of 22.87.
- For PBT Margin (%), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 10. It has increased from -18.72 (Mar 24) to 2.64, marking an increase of 21.36.
- For Net Profit Margin (%), as of Mar 25, the value is 1.86. This value is below the healthy minimum of 5. It has increased from -12.57 (Mar 24) to 1.86, marking an increase of 14.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 15. It has increased from -2.02 (Mar 24) to 0.63, marking an increase of 2.65.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 10. It has increased from -3.00 (Mar 24) to 1.41, marking an increase of 4.41.
- For Return On Assets (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has increased from -2.01 (Mar 24) to 0.60, marking an increase of 2.61.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has increased from 0.15 (Mar 24) to 0.33, marking an increase of 0.18.
- For Current Ratio (X), as of Mar 25, the value is 30.69. This value exceeds the healthy maximum of 3. It has decreased from 420.74 (Mar 24) to 30.69, marking a decrease of 390.05.
- For Quick Ratio (X), as of Mar 25, the value is 10.99. This value exceeds the healthy maximum of 2. It has decreased from 120.86 (Mar 24) to 10.99, marking a decrease of 109.87.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.50, marking an increase of 0.50.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.89. This value is below the healthy minimum of 3. It has increased from -580.06 (Mar 24) to 2.89, marking an increase of 582.95.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 3. It has increased from -390.23 (Mar 24) to 2.21, marking an increase of 392.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 23.72. It has decreased from 28.28 (Mar 24) to 23.72, marking a decrease of 4.56.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has decreased from 2.60 (Mar 24) to 1.03, marking a decrease of 1.57.
- For EV / EBITDA (X), as of Mar 25, the value is 23.23. This value exceeds the healthy maximum of 15. It has increased from -13.93 (Mar 24) to 23.23, marking an increase of 37.16.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 1.23, marking a decrease of 1.87.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.49 (Mar 24) to 0.41, marking a decrease of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 1.23, marking a decrease of 1.87.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 24) to 0.01, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zodiac JRD MKJ LTD:
- Net Profit Margin: 1.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.41% (Industry Average ROCE: 6.93%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.63% (Industry Average ROE: 5.13%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 10.99
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 67 (Industry average Stock P/E: 47.77)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.86%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Gems, Jewellery & Precious Metals | 506, 513, 5th Floor, 17G, Vardhaman Chamber, Mumbai Maharashtra 400001 | secretarial@zodiacjrdmkjltd.co.in http://www.zodiacjrdmkjltd.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mahesh Ratilal Shah | Managing Director |
| Mr. Mudit Sharadkumar Jain | Non Exe.Non Ind.Director |
| Mr. Dharmesh Pravin Kharwar | Non Exe. & Ind. Director |
| Mrs. Rupal Patel | Non Exe. & Ind. Director |
| Mr. Jitendra Kanhaiyalal Purohit | Non Exe. & Ind. Director |
| Mr. Marc Christopher Weinmann | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Zodiac JRD MKJ LTD?
Zodiac JRD MKJ LTD's intrinsic value (as of 19 December 2025) is 29.08 which is 23.07% lower the current market price of 37.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 41.5 Cr. market cap, FY2025-2026 high/low of 73.0/36.2, reserves of ₹80.23 Cr, and liabilities of 94.67 Cr.
What is the Market Cap of Zodiac JRD MKJ LTD?
The Market Cap of Zodiac JRD MKJ LTD is 41.5 Cr..
What is the current Stock Price of Zodiac JRD MKJ LTD as on 19 December 2025?
The current stock price of Zodiac JRD MKJ LTD as on 19 December 2025 is 37.8.
What is the High / Low of Zodiac JRD MKJ LTD stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Zodiac JRD MKJ LTD stocks is 73.0/36.2.
What is the Stock P/E of Zodiac JRD MKJ LTD?
The Stock P/E of Zodiac JRD MKJ LTD is 67.0.
What is the Book Value of Zodiac JRD MKJ LTD?
The Book Value of Zodiac JRD MKJ LTD is 83.1.
What is the Dividend Yield of Zodiac JRD MKJ LTD?
The Dividend Yield of Zodiac JRD MKJ LTD is 0.00 %.
What is the ROCE of Zodiac JRD MKJ LTD?
The ROCE of Zodiac JRD MKJ LTD is 1.41 %.
What is the ROE of Zodiac JRD MKJ LTD?
The ROE of Zodiac JRD MKJ LTD is 0.64 %.
What is the Face Value of Zodiac JRD MKJ LTD?
The Face Value of Zodiac JRD MKJ LTD is 10.0.